Journal: Molecular Psychiatry
Article Title: Risk assessment analysis for maternal autoantibody-related autism (MAR-ASD): a subtype of autism
doi: 10.1038/s41380-020-00998-8
Figure Lengend Snippet: Summary of clinically-relevant statistics of autoantibody-antigen reactivity combinations that are from 100 to 90% specific with ASD diagnosis in the training and validation set (combined data).
Article Snippet: The tag-less proteins CRMP1 #MBS7074427 and LDHA #MBS949692 were from MyBioSource (San Diego CA), GDA # NBP2-49692, LDHB #NBP2-49694, NSE #NBC1-18342, and STIP1 #NBP2-49685 were from Novus Biologicals (Centennial, CO), while CRMP2 and YBOX were custom made by Expression Systems using a baculovirus system (Davis, CA).
Techniques: Biomarker Discovery